CD8A and neoplasm: In the context of GBM treatment using G47Δ, a third-generation oncolytic HSV-1 with triple mutations, a significant augmentation in CD4+ and CD8+ lymphocyte populations was observed as they rapidly infiltrated into tumor tissue.